Actionable news
All posts from Actionable news
Actionable news in NVAX: Novavax, Inc.,

How Will Novavax (NVAX) Stock React After Q2 Miss?

NEW YORK (TheStreet) -- Shares of Novavax (NVAX) were flat in after-hours trading on Tuesday following the company's lower-than-expected second quarter results.

After today's market close, the Rockville, MD-based clinical-stage vaccine company reported a loss of 29 cents per share, while analysts were looking for a loss of 25 cents per share. Revenue fell 82% year-over-year to $2.51 million, missing Wall Street's expected $8.03 million.

Sales declined significantly due to lower revenue under the BARDA contract...